INTRODUCTION
============

Expression of K^+^ channels is developmentally regulated in cochlear outer hair cells (OHCs). Before hearing onset, delayed rectifier K^+^ current (*I*~K,emb~, *I*~K,neo~) \[[@B1]\], inward rectifier K^+^ current (*I*~K1~) \[[@B2]\], small conductance Ca^2+^ activated K^+^ current (*I*~SK~) \[[@B3][@B4]\], and K^+^ current activated at negative potentials (*I*~K,n~) are sequentially expressed in murine cochlear OHCs \[[@B5]\]. The reports, which suggest that the timely expression of K^+^ channels is important for the functional maturation of cochlear hair cells \[[@B1][@B5][@B6]\], raise a possibility that K^+^ channel expression in the early stage might be different in the cochlear hair cells of genetically abnormal animals, such as mouse models for human deafness.

We reported \[[@B7]\] the characteristics of K^+^ outward currents recorded in the OHCs of immature circling mouse (P0\~P6), a mouse model for human deafness (DFNB6 type) \[[@B8][@B9]\], as a scanning electron microscope study demonstrated that the stereocilliary defects of OHCs were observable as early as P10 and were more severe in the OHCs than in the inner hair cells (IHCs) at P18 in circling mice \[[@B10]\].

This is a study following the previous study which demonstrated the subtle biophysical and pharmacological differences between circling mice (homozygous (*cir*/*cir*) mice) and their littermates (heterozygous (+/*cir*) mice). While investigating the pharmacological aspects of K^+^ outward currents in the previous study \[[@B7]\], we tested TEA and 4-AP only, not linopirdine, a known inhibitor of *I*~K,n~, as *I*~K,n~ is not reported to develop before P6 in mice OHCs \[[@B5]\]. However, from succeeding experiments using linopirdine, we found significant inhibitory effects of linopirdine on K^+^ outward currents of P0\~P6 heterozygous (+/*cir*) or homozygous (*cir*/*cir*) mice and we will discuss this finding in this report.

METHODS
=======

Animal and cochlear preparation
-------------------------------

Female heterozygous (+/*cir*) mice were mated with male homozygous (*cir*/*cir*) mice (circling mice), and their offspring were used in this study. The circling mice strain has been maintained for more than 10 generations by breeding between female heterozygous (+/*cir*) mice and their male siblings (homozygous (*cir*/*cir*) mice) at the Animal Facility of Dankook University since 2007. The data presented were obtained from pups between P0 and P6. Genotypes were assessed by polymerase chain reaction analysis according to our previous report \[[@B11]\]. The Dankook University Institutional Animal Care and Use Committee (DUIAC) approved this study.

After the mice received deep anesthesia with isoflurane, their cochleae were removed and dissected in an ice-cold solution composed of (in mM): NaCl (124), KCl (5), KH~2~PO~4~ (1.25), glucose (10), NaHCO~3~ (26), CaCl~2~ (2), MgSO~4~ (1.3), and sucrose (20). The pH was 7.4 when aerated with 95% O~2~ and 5% CO~2~ and the osmolarity was about 305 mOsm. After removing the bony part and modiolus, the dissected cochleae were transferred to a submersion-type chamber mounted on an upright microscope and immobilized under a nylon mesh fixed to a stainless steel ring. The chamber was perfused continuously with the same solution used during preparation.

Electrical recording
--------------------

Whole cell currents were recorded from OHCs located in the middle turn of the cochlea. All experiments were performed at room temperature using an EPC-8 (HEKA, Lambrecht, Germany) amplifier. Electrodes (3\~5 MΩ) were filled with a solution containing (in mM): K-gluconate (108), EGTA (0.6), KCl (5), HEPES (10), Na~2~GTP (0.3), MgATP (1), KOH (30), sucrose (47), and QX 314 (5). All chemicals except for QX 314 (Tocris) were purchased from Sigma Chemicals Co., unless otherwise stated. Except for fast capacitance cancellation at the cell-attached stage, series resistance was not compensated and no corrections were made for the liquid junction potentials. The data were filtered at 5 kHz (EPC-8, HEKA), digitized at 10 kHz, and stored in the computer via a home-made program (R-Clamp 1.23) for offline analysis. The stored data were analyzed using Clampfit 9.0 (Molecular Devices), Origin 7.0 (Origin Lab). Data were expressed as the mean±SEM. An independent t-test was used for comparisons. Null hypotheses of no difference were rejected if p values were \<.05.

RESULTS
=======

Characteristics of K^+^ currents expressed in OHCs during the first postnatal week
----------------------------------------------------------------------------------

Depolarizing voltage steps from --100 mV to 40 mV (holding potential: --60 mV) evoked small inward (\<100 pA) and slowly inactivating outward K^+^ currents in the OHCs of all mice tested. In [Fig. 1A](#F1){ref-type="fig"}, only the data obtained from ICR mice was presented, as those for heterozygous (+/*cir*) and homozygous (*cir*/*cir*) were already presented in the previous paper \[[@B7]\]. All the K^+^ outward currents were similar to that reported previously (a delayed rectifier-type K^+^ current, *I*~K,neo~ \[[@B1]\], for neonatal cells). The outward currents activated at potentials close to --50 mV in all mice tested. Small inward currents did not show any active current decay, which was usually observed in mice OHCs older than P9 \[[@B5]\] even at --120 mV (Data not shown). The current density-voltage relation of ICR mice is presented in [Fig. 1B](#F1){ref-type="fig"}. The current density measured at 40 mV was 212.6±20.8 pA/pF in ICR mice (n=11). (In the previous paper \[[@B7]\], they were 227.1±18.9 pA/pF (n=16) in heterozygous (+/*cir*) mice and 238.9±14.3 pA/pF (n=22) in homozygous (*cir*/*cir*) mice).

Activation curves were derived from tail currents at --30 mV. The activation curves shown in [Fig. 1C](#F1){ref-type="fig"} were obtained by plotting the normalized tail currents against different prepulse potentials from --90 mV to 40 mV. Data were fitted by a modified first-order Boltzmann equation: y=A~2~+(A~1~--A~2~)/{1+exp(V-V~half~/S)} where y is the normalized peak current, A~2~ is the minimal normalized peak current, A~1~ is the maximal normalized peak current, V~half~ is the potential of half-maximal activation, V is the commanding potential, and S is the slope factor representing the voltage sensitivity of activation. V~half~ was --20.7±4.7 mV (n=7, ICR mice), --21.3±1.7 mV (n=9, heterozygous (+/*cir*) mice), and --20.8±3.3 mV (n=11, homozygous (*cir*/*cir*) mice). The slope factor was 9.8±0.9 mV (n=7, ICR mice), 13.8±1.8 (n=9, heterozygous (+/*cir*) mice) and 11.4±1.0 mV (n=11, homozygous (*cir*/*cir*) mice). They were not significantly different. In the previous paper, the reported values of V~half~s were --8.1 (heterozygous (+/*cir*) mice) and --17.2 (homozygous (*cir*/*cir*) mice) \[[@B7]\]. In the previous paper, the activation curves were derived by calculating conductance (peak current/(V~command~--V~holding~)) at each commanding potential (V~holding~=--60 mV), while in this paper, we used the tail current analysis. This might be the cause of the difference in V~half~s.

Sensitivity of K^+^ currents to linopirdine
-------------------------------------------

The above results indicated that biophysical properties of OHC K^+^ outward currents of heterozygous (+/*cir*), homozygous (*cir*/*cir*), and ICR mice were similar but quite different from those of *I*~K,n~ reported in OHCs of older mice aged more than P9 \[[@B5]\] in which 1) hyperpolarizing voltage steps elicited only small inward K^+^ currents, 2) they did not show any active decay and 3) outward currents activated at potentials close to --50 mV, while they activated at potentials negative to --100 mV in OHCs older than P9 when *I*~K,n~ developed fully, which suggested that K^+^ outward currents do not have the *I*~K,n~ component. In spite of this, we tested the effects of linopirdine (1, 10, and 100 µM), a known blocker of *I*~K,n~ to confirm that *I*~K,n~ did not develop early in OHCs of homozygous (*cir*/*cir*) or heterozygous (+/*cir*) mice.

K^+^ currents were elicited by a series of voltage steps from --60 mV to 40 mV (holding potential: --60 mV) and the current amplitudes were measured at the end of the voltage steps (200 ms) for analysis. The responses of K^+^ outward currents were not simple but were categorized into 2 or 3 groups (severe, moderate, mild) according to the extent of inhibition by linopirdine in homozygous (*cir*/*cir*) or heterozygous (+/*cir*) mice. Among 13 cells of homozygous (*cir*/*cir*) mice, 5 cells showed a severe block, 4 cells showed a moderate block, and 4 cells showed a mild block. In 5 cells showing a severe block, the K^+^ current recorded at 40 mV was reduced to 51.0±1.6% (n=5), 33.1±6.1% (n=5), and 15.7±2.1% (n=5) of the control by 1 µM, 10 µM, and 100 µM linopirdine, respectively ([Fig. 2A](#F2){ref-type="fig"}). In 4 cells showing a moderate block, the corresponding values were 69.5±5.3% (n=4), 56.7±3.0% (n=4), and 33.8±2.3% (n=4) of the control by 1 µM, 10 µM, and 100 µM linopirdine, respectively ([Fig. 2B](#F2){ref-type="fig"}). Among 4 cells showing a mild block, we succeeded in observing a 100 µM response only in one cell. In the remaining 3 cells, we only observed the effects of linopirdine up to 10 µM. The K^+^ current at 40 mV was reduced to 91.7±4.7% (n=3, 1 µM) and 85.7±1.0% (n=3, 10 µM). The 100 µM response in one cell is shown in [Fig. 2C](#F2){ref-type="fig"}. The currents at 40 mV were reduced to 90.5% (1 µM), 85.7% (10 µM), and 42.8% (100 µM). Linopirdine was not effective at hyperpolarizing voltages (--100 mV\~--70 mV). [Fig. 2D](#F2){ref-type="fig"} shows the representative data. No inhibition at the hyperpolarizing voltages was also observed in heterozygous (+/*cir*) and ICR mice (data not shown).

Among 10 cells of heterozygous (+/*cir*) mice, 4 cells showed a severe block and 6 cells showed a moderate block. In the OHCs of heterozygous (+/*cir*) mice showing a severe block, the current was reduced to 62.1±3.1% (n=4, 1 µM), 25.0±4.5% (n=4, 10 µM), and 8.9±3.5% (n=4, 100 µM) ([Fig. 3A](#F3){ref-type="fig"}), while in the OHCs showing a moderate block, the values were 75.7±6.6% (n=6, 1 µM) and 55.4±3.4% (n=6, 10 µM) ([Fig. 3B](#F3){ref-type="fig"}). We failed to record a 100 µM response in cells showing a moderate block.

In ICR mice, linopirdine responses were quite different from those in homozygous (*cir*/*cir*) or heterozygous (+/*cir*) mice. There were no cells showing a severe block caused by linopirdine among the total 9 cells recorded. We succeeded in observing a 100 µM response only in one cell among the 9 cells recorded. In the remaining 8 cells, responses only up to 10 µM were observed. In 8 cells, the currents were reduced to 93.6±1.4% (n=8, 1 µM) and 90.5±2.7% (n=8, 10 µM) ([Fig. 4B](#F4){ref-type="fig"}). In one cell, the currents at 40 mV were reduced to 94.7% (1 µM), 92.1% (10 µM), and 50.4% (100 µM) ([Fig. 4A](#F4){ref-type="fig"}).

We also checked the effects of linopirdine on small inward currents recorded by hyperpolarizing voltage steps (from --100 mV to --70 mV). However, we did not observe any inhibition in this voltage range in all cells tested (data not shown).

DISCUSSION
==========

Currently, only two types of K^+^ currents, a transiently expressed inward rectifier (*I*~K1~) \[[@B2]\] and a delayed rectifier-type outward (*I*~K,neo~) \[[@B1][@B12]\], have been reported in P0\~P6 mice OHCs. A small conductance Ca^2+^-activated K^+^ current (*I*~SK~)(\>P6) \[[@B3][@B4]\] and a K^+^ current activated at negative potentials (*I*~K..n~) (\>P8) are the next ones expected to develop in OHCs \[[@B5]\]. In this report, we showed the varying degree of inhibition of K^+^ currents by linopirdine, an inhibitor of members of the KCNQ family K^+^ channels \[[@B13][@B14][@B15]\], in K^+^ outward currents of P0\~P6 heterozygous (+/*cir*) or homozygous (*cir*/*cir*) mice OHCs. Although the IC~50~s values (1\~10 µM, in cases of a severe block in homozygous (*cir*/*cir*) or heterozygous (+/*cir*) mice) fall within the reported range of values for the inhibition of KCNQ currents \[[@B14][@B15][@B16]\], we do not think it likely that the K^+^ outward currents have some component of *I*~K,n~ which develops earlier than expected in homozygous (*cir*/*cir*) or heterozygous (+/*cir*) mice OHCs, as the biophysical and pharmacological properties of K^+^ currents in this study do not match well with those of *I*~K,n~ reported in guinea-pig \[[@B17]\] or mice OHCs \[[@B5]\]. The possibility of the involvement of *I*~SK~ was ruled out in the previous study with respect to TEA sensitivity \[[@B7]\].

Firstly, unlike *I*~K,n~ reported in guinea-pig \[[@B17]\] or mice \[[@B5]\], hyperpolarizing voltage steps elicited only small inward currents without active current decay in P0\~P6 heterozygous (+/*cir*) and homozygous (*cir*/*cir*) mice. This small inward current (less than 100 pA at --100 mV) might be influenced by a holding potential of --60 mV. However, regardless of the holding potential, *I*~K,n~ was easily observable in OHCs where *I*~K,n~ was fully developed \[[@B5][@B17][@B18]\]. The fact that linopirdine did not inhibit inward currents recorded at hyperpolarizing voltage steps also supports the claim that *I*~K,n~ is not present in heterozygous (+/*cir*) or homozygous (*cir*/*cir*) mice OHCs.

Secondly, the activation curves obtained from homozygous (*cir*/*cir*) and heterozygous (+/*cir*) mice are similar to that obtained from P6 mice OHC in which K^+^ outward currents activate at potentials close to --50 mV, whereas they activate at potentials negative to --100 mV in P12 mice OHCs where *I*~K,n~ is already developed \[[@B5]\].

Thirdly, K^+^ outward currents in homozygous (*cir*/*cir*) or heterozygous (+/*cir*) mice are sensitively blocked by TEA in the millimolar range \[[@B7]\]. We do not know the underlying ion channel subtypes of the K^+^ outward currents of heterozygous (+/*cir*) or homozygous (*cir*/*cir*) mice OHCs, but if it is KCNQ4 as suggested by Marcotti and Kros in developing mice OHCs \[[@B5]\], it is not in line with our results because KCNQ4 is known to be relatively insensitive to TEA \[[@B19][@B20]\]. Moreover, the fact that linopirdine did not cause any further inhibition after K^+^ currents were fully inhibited by TEA (data not shown) in heterozygous (+/*cir*) or homozygous (*cir*/*cir*) mice also supports our notion.

Marcotti and Kros reported that linopirdine up to 200 µM was not effective at all in immature mice OHCs (\<P6) \[[@B5]\]. Up to 10 µM linopirdine, we observed similar results in ICR mice OHCs; however, in one cell, we did observe that 100 µM linopirdine inhibited K^+^ current at 40 mV by 50%. In hippocampal neurons, it was reported that linopirdine exceeding 100 µM inhibited the delayed rectifier K^+^ currents by 50% \[[@B21]\]. Considering the non-specific blocking effects of linopirdine on other currents \[[@B21][@B22]\], K^+^ current inhibition by a high concentration of linopirdine might not be surprising even in immature OHCs. Species difference should be considered.

In this study, we showed the varying degree of inhibition (severe, moderate, mild) by linopirdine. This indicates that developing OHCs are not homogeneous with respect to ion channel expression. We usually used cells located in the cochlear middle turn, but not always those in the same low and the same location. It is not clear whether this inhomogeneity stems from positional difference along the organ of Corti or other unknown factors.

The purpose of this study was to investigate the ion channels contributing to OHC degeneration starting from the second postnatal week in homozygous (*cir*/*cir*) mice \[[@B10]\]. We do not know the exact function of this linopirdine-sensitive K^+^ channel in the development of homozygous (*cir*/*cir*) mice OHCs, but it can be suggested that this K^+^ channel does not play a significant role in OHC degeneration because a similar K^+^ channel is also expressed early in heterozygous (+/*cir*) mice OHCs.
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![Whole cell K^+^ currents of P0\~P6 mice OHCs. Current traces recorded from P6 ICR mice is shown in A.\
Currents were elicited by depolarizing voltage steps from --100 mV to 40 mV with 10 mV increment (holding potential: --60 mV). Voltage protocol is shown above the current traces. Current density-voltage curve of ICR mice is shown in B. Activation curves for ICR, heterozygous (+/*cir*), and homozygous (*cir*/*cir*) mice are shown in C (filled square: ICR, filled circle: heterozygous (+/*cir*) mouse (Hetero), hollow circle: homozygous (*cir*/*cir*) mouse (Homo)). The activation curves in C were obtained by plotting the normalized tail currents at -30 mV against different prepulse potentials (--90 mV\~40 mV). The voltage protocol and tail currents are shown in inset.](kjpp-21-251-g001){#F1}

![Effect of linopirdine on K^+^ currents in homozygous (*cir*/*cir*) mice OHCs.\
The varying degree of inhibition of K^+^ currents by linopirdine (1 to 100 µM) is shown in A, B, and C. Currents were elicited by depolarizing voltage steps from --60 mV to 40 mV (the holding potential was --60 mV). Reduced currents were normalized (I/I~max~) with the peak currents at 40 mV before drug application. Normalized currents -- voltage curves are shown in Ae, Be, and Ce. Marks above the current traces indicate the measuring points and linopirdine concentrations. [Fig. 2C](#F2){ref-type="fig"} shows the linopirdine effects recorded in one cell. [Fig. 2D](#F2){ref-type="fig"} shows the linopirdine effects recorded in one cell, currents were elicited by depolarizing voltage steps from --100 mV to 40 mV (the holding potential was --60 mV). Linopirdine was not effective at hyperpolarizing voltage range (--100 mV\~--60 mV).](kjpp-21-251-g002){#F2}

![Effect of linopirdine on K^+^ currents in heterozygous (+/*cir*) mice OHCs.\
The varying degree of inhibition of K^+^ currents by linopirdine is shown in A (1 to 100 µM) and B (1 to 10 µM). Currents were elicited by depolarizing voltage steps from --60 mV to 40 mV (the holding potential was --60 mV). Reduced currents were normalized (I/I~max~) with peak currents at 40 mV before drug application. Normalized currents--voltage curves are shown in Ae and Bd. Marks above the current traces indicate the measuring points and linopirdine concentrations.](kjpp-21-251-g003){#F3}

![Effect of linopirdine on K^+^ currents in ICR mice OHCs.\
The varying degree of inhibition of K+ currents by linopirdine is shown in A (1 to 100 µM) and B (1 to 10 µM). Currents were elicited by depolarizing voltage steps from --60 mV to 40 mV (the holding potential was --60 mV). Reduced currents were normalized (I/I~max~) with peak currents at 40 mV before drug application. Normalized currents-voltage curves are shown in Ae and B. Marks above the current traces indicate the measuring points and linopirdine concentrations. [Fig. 4Aa\~4Ae](#F4){ref-type="fig"} show the linopirdine effects recorded in one cell. [Fig. 4B](#F4){ref-type="fig"} shows normalized currents-voltage curves obtained from the cells treated with linopirdine up to 10 µM.](kjpp-21-251-g004){#F4}
